HOME >> BIOLOGY >> NEWS
Whitaker Foundation funds Washington University biomedical engineering facility

me a national leader in an important field that is bringing to the world breakthroughs in human health every day."

"We are extremely pleased to have the support of The Whitaker Foundation to build a world-class biomedical engineering department," stated Frank C.P. Yin, M.D., Ph.D., chair of the department and director of the university's Institute of Biological and Medical Engineering. (Yin also is Steven F. and Camilla T. Brauer Professor of Biomedical Engineering.) "We will be recruiting a mix of outstanding senior and junior faculty. Once the building and the new faculty are in place, we will be more than ready to meet the demand for biomedical engineering, which already is extremely popular with our students."

Christopher I. Byrnes, dean of the School of Engineering and Applied Sciences, said this high demand was anticipated early on in the planning for the 21st century. "The need for a strong biomedical engineering department was identified as one of the school's top priorities during our Project 21 planning process," Byrnes noted.

Recognizing the need to begin building a biomedical engineering center, the new department was introduced in the fall of 1997, with 50 freshman students expressing an interest in a major. This fall, nearly one-third of the 270 incoming engineering freshmen have declared an interest in the biomedical engineering major. Roughly half of the engineering students earning a bachelor's degree pursue a medical degree, with the other half going into industry or academia. The department currently enrolls 29 graduate students, 19 doctoral candidates and 10 master's degree students.

"The Biomedical Engineering department has been growing steadily, with the resulting growing pains," said Byrnes. "The Foundation's awards will transform the young department with limited space into a major center of research and teaching."

While the young department is small, with a core faculty of five full-time
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
4-Nov-1999


Page: 1 2 3 4

Related biology news :

1. Whitaker Foundation to phase out grant programs
2. UC Davis biomedical engineering department awarded $12 million by Whitaker Foundation
3. Whitaker makes largest individual grants ever totaling more than $30 million
4. Whitaker Foundation To Fund AAAS Science Journalism Awards Through 2001
5. Whitaker Awards $6.8 Million For Biomedical Engineering Education
6. Brown ecologist garners major National Science Foundation grant
7. APS Foundation names student travel award recipients
8. Institute for OneWorld Health receives Gates Foundation grant
9. National Parkinson Foundation designates UNC as Center of Excellence
10. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
11. Leslie Ann Schiff wins 2004 Carski Foundation Award

Post Your Comments:
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
(Date:3/4/2015)... , March 4, 2015  BioClinica®, Inc., ... technology provider, today announced that clinical trial ... convened at its annual European User Conference ... to discuss the use of its eClinical ... eClinical technologies include: the Microsoft Office-Smart OnPoint ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... (PCR) represents one of the fastest growing technologies in ... biologists in subcellular visualization is driving growth in nucleic ... for deeper understanding of gene expressions will continue to ... Expanding applications in fields ranging from pharma, biotech, food ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
Cached News: